Neugenesis Corporation
Biomedicines for the 21st Century
Over the last decade, Neugenesis has developed new technology for rapid and inexpensive discovery and production of high value biopharmaceutical drugs.
The company has created proprietary platforms which provide:
- Better ways to produce complex drugs including
- multivalent vaccines Press Release, Red Herring Coverage
- monoclonal antibodies [Press Release]
- and new ways to improve these products using
- directed evolution and
- combinatorial biology
Neugenesis uses its propriety technologies to support its internal biopharmaceutical pipeline. In addition, Neugenesis contracts and licenses its proprietary technologies to industry clients working in non-competing areas. The Neugenesis technologies are simple, inexpensive, and elegant. They are the result of the company's ability to leverage fundamental biological research into commercial biotechnology applications.